Literature DB >> 21594681

Influence of diabetes mellitus on vertebral fractures in men with acromegaly.

Gherardo Mazziotti1, Monica Gola, Antonio Bianchi, Teresa Porcelli, Antonella Giampietro, Vincenzo Cimino, Mauro Doga, Carmine Gazzaruso, Laura De Marinis, Andrea Giustina.   

Abstract

Acromegaly is frequently complicated by fragility vertebral fractures and diabetes mellitus. Since type 2 diabetes mellitus is a cause of secondary osteoporosis in the general population, in this cross-sectional study we aimed at investigating the association between diabetes mellitus and vertebral fractures in males with acromegaly. Fifty-seven patients (median age 47 years, range: 24-85) with active (21 cases) and controlled (36 cases) acromegaly and 57 control subjects were evaluated for bone mineral density (BMD) by DXA and vertebral fractures by a quantitative morphometric analysis. Diabetes mellitus was found in 18 patients and 18 control subjects. The prevalence of vertebral fractures was higher in acromegalic patients as compared with the control subjects (50.9 vs. 10.5%; χ(2): 21.8; P < 0.001). Acromegalic patients with fractures had serum IGF-I values significantly higher (P = 0.009), longer duration of active disease (P < 0.001) and higher prevalence of active acromegaly (P = 0.007) and diabetes mellitus (P = 0.04) as compared to patients who did not fracture. When acromegaly was active, the prevalence of vertebral fractures was high independently of the coexistent diabetes mellitus. On the contrary, when acromegaly was controlled the prevalence of vertebral fractures was significantly higher in patients with diabetes as compared to patients without diabetes (62.6 vs. 28.0%; P = 0.04). In both diabetic and non diabetic patients, vertebral fractures occurred independently of BMD. In conclusion, this study suggests that diabetes mellitus may be associated with an increased prevalence of vertebral fractures in males with acromegaly. However, this effect seems to be relatively attenuated in the presence of persistent GH hypersecretion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594681     DOI: 10.1007/s12020-011-9486-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes.

Authors:  S Bossoni; G Mazziotti; C Gazzaruso; D Martinelli; S Orini; S B Solerte; G Romanelli; A Giustina
Journal:  Age Ageing       Date:  2007-11-21       Impact factor: 10.668

2.  Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly.

Authors:  T Ueland; E N Ebbesen; J S Thomsen; L Mosekilde; K Brixen; A Flyvbjerg; J Bollerslev
Journal:  Eur J Clin Invest       Date:  2002-02       Impact factor: 4.686

3.  Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  Eur J Endocrinol       Date:  2008-11-07       Impact factor: 6.664

4.  Prevalence of vertebral fractures in men with acromegaly.

Authors:  Gherardo Mazziotti; Antonio Bianchi; Stefania Bonadonna; Vincenzo Cimino; Ilaria Patelli; Alessandra Fusco; Alfredo Pontecorvi; Laura De Marinis; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

5.  Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.

Authors:  Alfredo Scillitani; Claudia Battista; Iacopo Chiodini; Vincenzo Carnevale; Saverio Fusilli; Enrica Ciccarelli; Massimo Terzolo; Giuseppe Oppizzi; Maura Arosio; Maurizio Gasperi; Giorgio Arnaldi; Annamaria Colao; Roberto Baldelli; Maria Rosaria Ghiggi; Daniela Gaia; Carolina Di Somma; Vincenzo Trischitta; Antonio Liuzzi
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

6.  Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.

Authors:  G Mazziotti; S Bonadonna; M Doga; I Patelli; C Gazzaruso; S B Solerte; E De Menis; A Giustina
Journal:  Neuroendocrinology       Date:  2008-07-10       Impact factor: 4.914

Review 7.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

8.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

9.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

10.  A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.

Authors:  Nuria Sucunza; M José Barahona; Eugenia Resmini; Jose-Manuel Fernández-Real; Wifredo Ricart; Jordi Farrerons; José Rodríguez Espinosa; Ana-María Marin; Teresa Puig; Susan M Webb
Journal:  J Clin Endocrinol Metab       Date:  2009-09-01       Impact factor: 5.958

View more
  17 in total

1.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

Review 2.  The association between metabolic syndrome and bone mineral density: a meta-analysis.

Authors:  Peng Xue; Ping Gao; Yukun Li
Journal:  Endocrine       Date:  2012-05-01       Impact factor: 3.633

3.  An increased risk for fractures: another cause of frailty in HIV-infected subjects.

Authors:  Carmine Gazzaruso
Journal:  Endocrine       Date:  2012-06       Impact factor: 3.633

4.  Optimal use of pegvisomant in acromegaly: are we getting there?

Authors:  Andrea Giustina
Journal:  Endocrine       Date:  2014-10-28       Impact factor: 3.633

5.  Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women.

Authors:  Hongbing Zhang; Xiangping Chai; Shuang Li; Zhimin Zhang; Lingqing Yuan; Hui Xie; Houde Zhou; Xiyu Wu; Zhifeng Sheng; Eryuan Liao
Journal:  Endocrine       Date:  2012-11-19       Impact factor: 3.633

Review 6.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 7.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

8.  Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model.

Authors:  Baoxin Li; Yan Wang; Yan Liu; Jianxia Ma; Yukun Li
Journal:  Endocrine       Date:  2012-07-22       Impact factor: 3.633

9.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

10.  Is every joint symptom related to acromegaly?

Authors:  Gonca Örük; Figen Tarhan; Mehmet Argın; Mustafa Özmen
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.